T. Rowe Price Associates’s Bausch Health BHC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1,402,927
| Closed | -$39.1M | – | 2983 |
|
2021
Q3 | $39.1M | Sell |
1,402,927
-6,447,646
| -82% | -$180M | ﹤0.01% | 1103 |
|
2021
Q2 | $230M | Buy |
7,850,573
+2,553,297
| +48% | +$74.9M | 0.02% | 524 |
|
2021
Q1 | $168M | Sell |
5,297,276
-572,585
| -10% | -$18.2M | 0.02% | 600 |
|
2020
Q4 | $122M | Sell |
5,869,861
-4,952,841
| -46% | -$103M | 0.01% | 669 |
|
2020
Q3 | $168M | Buy |
10,822,702
+2,038,156
| +23% | +$31.7M | 0.02% | 527 |
|
2020
Q2 | $161M | Buy |
8,784,546
+6,269,935
| +249% | +$115M | 0.02% | 517 |
|
2020
Q1 | $39M | Buy |
+2,514,611
| New | +$39M | 0.01% | 861 |
|
2018
Q3 | – | Sell |
-9,200
| Closed | -$214K | – | 2571 |
|
2018
Q2 | $214K | Buy |
+9,200
| New | +$214K | ﹤0.01% | 2428 |
|
2016
Q4 | – | Sell |
-1,722,415
| Closed | -$42.2M | – | 2549 |
|
2016
Q3 | $42.2M | Buy |
1,722,415
+239,261
| +16% | +$5.87M | 0.01% | 869 |
|
2016
Q2 | $29.8M | Sell |
1,483,154
-665,647
| -31% | -$13.4M | 0.01% | 969 |
|
2016
Q1 | $56.5M | Sell |
2,148,801
-19,705,013
| -90% | -$518M | 0.01% | 725 |
|
2015
Q4 | $2.22B | Buy |
21,853,814
+1,806,903
| +9% | +$184M | 0.47% | 43 |
|
2015
Q3 | $3.58B | Sell |
20,046,911
-416,721
| -2% | -$74.3M | 0.8% | 17 |
|
2015
Q2 | $4.55B | Buy |
20,463,632
+338,296
| +2% | +$75.1M | 0.93% | 14 |
|
2015
Q1 | $4B | Buy |
20,125,336
+2,283,052
| +13% | +$453M | 0.83% | 16 |
|
2014
Q4 | $2.55B | Buy |
17,842,284
+345,074
| +2% | +$49.4M | 0.54% | 34 |
|
2014
Q3 | $2.3B | Buy |
17,497,210
+1,041,503
| +6% | +$137M | 0.5% | 46 |
|
2014
Q2 | $2.08B | Buy |
16,455,707
+2,398,880
| +17% | +$303M | 0.45% | 52 |
|
2014
Q1 | $1.85B | Sell |
14,056,827
-726,776
| -5% | -$95.8M | 0.42% | 49 |
|
2013
Q4 | $1.74B | Sell |
14,783,603
-720,732
| -5% | -$84.6M | 0.4% | 55 |
|
2013
Q3 | $1.62B | Buy |
15,504,335
+13,065
| +0.1% | +$1.36M | 0.4% | 59 |
|
2013
Q2 | $1.33B | Buy |
+15,491,270
| New | +$1.33B | 0.36% | 66 |
|